The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis

被引:73
|
作者
O'Dwyer, Donna [1 ]
Ralton, Lynda D. [1 ]
O'Shea, Aisling [1 ]
Murray, Graeme I. [1 ]
机构
[1] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland
来源
PLOS ONE | 2011年 / 6卷 / 11期
基金
英国生物技术与生命科学研究理事会;
关键词
POOR-PROGNOSIS; EXPRESSION; MARKERS; BIOMARKERS; THERAPY; HSP60; CYTOCHROME-P450; PREDICTION; ANNEXINS; GROWTH;
D O I
10.1371/journal.pone.0027718
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Colorectal cancer is one of the commonest types of cancer and there is requirement for the identification of prognostic biomarkers. In this study protein expression profiles have been established for colorectal cancer and normal colonic mucosa by proteomics using a combination of two dimensional gel electrophoresis with fresh frozen sections of paired Dukes B colorectal cancer and normal colorectal mucosa (n = 28), gel image analysis and high performance liquid chromatography-tandem mass spectrometry. Hierarchical cluster analysis and principal components analysis showed that the protein expression profiles of colorectal cancer and normal colonic mucosa clustered into distinct patterns of protein expression. Forty-five proteins were identified as showing at least 1.5 times increased expression in colorectal cancer and the identity of these proteins was confirmed by liquid chromatography-tandem mass spectrometry. Fifteen proteins that showed increased expression were validated by immunohistochemistry using a well characterised colorectal cancer tissue microarray containing 515 primary colorectal cancer, 224 lymph node metastasis and 50 normal colonic mucosal samples. The proteins that showed the greatest degree of overexpression in primary colorectal cancer compared with normal colonic mucosa were heat shock protein 60 (p < 0.001), S100A9 (p < 0.001) and translationally controlled tumour protein (p, 0.001). Analysis of proteins individually identified 14-3-3 beta as a prognostic biomarker (chi(2) = 6.218, p = 0.013, HR = 0.639, 95% CL 0.448-0.913). Hierarchical cluster analysis identified distinct phenotypes associated with survival and a two-protein signature consisting of 14-3-3b and aldehyde dehydrogenase 1 was identified as showing prognostic significance (chi(2) = 7.306, p = 0.007, HR = 0.504, 95% CL 0.303-0.838) and that remained independently prognostic (p = 0.01, HR = 0.416, 95% CL 0.208-0.829) in a multivariate model.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] A Novel Pyroptosis-Associated Gene Signature to Predict Prognosis in Patients with Colorectal Cancer
    Dai, Juji
    Chen, Shuangdong
    Bai, Yongyu
    Fu, Yangyang
    Pan, Yifei
    Ye, Lechi
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [22] Identification of DNA methylation characteristics associated with metastasis and prognosis in colorectal cancer
    Qian, Fang
    Li, Qiang
    Chang, Huidan
    Wei, Kai
    Chen, Xiaoyi
    Huang, Tao
    Li, Yixue
    BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [23] Biomarker Identification through Proteomics in Colorectal Cancer
    Martin-Garcia, Desiree
    Garcia-Aranda, Marilina
    Redondo, Maximino
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
  • [24] Colorectal Cancer Biomarker Identification: A Proteomics Approach
    Ralton, L.
    Murray, G.
    JOURNAL OF PATHOLOGY, 2010, 222 : S44 - S44
  • [25] Biomarkers for Colorectal Cancer: Identification Through Proteomics
    Ralton, Lynda D.
    Murray, Graeme I.
    CURRENT PROTEOMICS, 2010, 7 (04) : 212 - 221
  • [26] Biomarkers for Colorectal Cancer: Identification Through Proteomics
    Ralton, Lynda D.
    Murray, Graeme I.
    CURRENT PROTEOMICS, 2010, 7 (03) : 212 - 221
  • [27] Identification of cancer-associated proteins by proteomics and downregulation of β-tropomyosin expression in colorectal adenoma and cancer
    Luo, Yan-Xin
    Cui, Ji
    Wang, Lei
    Chen, Dian-Ke
    Peng, Jun-Sheng
    Lan, Ping
    Huang, Mei-Jin
    Huang, Yi-Hua
    Cai, Shi-Rong
    Hu, Kun-Hua
    Li, Ming-Tao
    Wang, Jian-Ping
    PROTEOMICS CLINICAL APPLICATIONS, 2009, 3 (12) : 1397 - 1406
  • [28] Identification of Fusobacterium nucleatum associated immune features and proteomic signature in colorectal cancer
    Dadgar, Neda
    Xie, Jianwu
    Park, Hyun
    Zhang, Qiangmin
    Peng, Xi
    Kevin, Kunhong
    Wagner, Patrick L.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S123 - S124
  • [29] Identification of a novel gut microbiota signature associated with colorectal cancer in Thai population
    Iadsee, Nutta
    Chuaypen, Natthaya
    Techawiwattanaboon, Teerasit
    Jinato, Thananya
    Patcharatrakul, Tanisa
    Malakorn, Songphol
    Petchlorlian, Aisawan
    Praditpornsilpa, Kearkiat
    Patarakul, Kanitha
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [30] Identification of a novel gut microbiota signature associated with colorectal cancer in Thai population
    Nutta Iadsee
    Natthaya Chuaypen
    Teerasit Techawiwattanaboon
    Thananya Jinato
    Tanisa Patcharatrakul
    Songphol Malakorn
    Aisawan Petchlorlian
    Kearkiat Praditpornsilpa
    Kanitha Patarakul
    Scientific Reports, 13 (1)